Present | Name | Organization |
|---|
X | Nancy Cornish | CDC |
X | Manjula Gama-Ralalage | CDC |
X | Riki Merrick | APHL |
X | Christina Gallegos | APHL |
X | Amy Lui | Inductive Health / APHL |
X | Raj Dash | Duke / CAP |
X | John Snyder | National Library of Medicine (SNOMED CT) |
X | Andrea Pitkus | UW |
X | Kathy Walsh | Labcorp |
X | Rob Hausam | Hausam Consulting |
| Doug Franklin | APHL |
X | Pam Banning | 3M |
Discussion topics
Item | Notes |
|---|
Upcoming OOO | |
Review call notes from last week | Briefly done |
Presentation from National Cancer Surveillance Program at CDC to ONC | Nancy and Manjula were on this presentation last week Goal would be for ONC to understand more of this need and also to bring CMS into the discussion - CDC is working on adding more background to the slide deck to share it CMS is re-organizing, hopefully that will result in more support for interoperabilty - Nancy can share the paper:
Presentation idetified the need for data blob data to be turned into discrete data includes screening for cervical cancer 30% are using the electronic Cancer Checklist (eCCs) in the US, 90% in Canada - now called protocols even if labs use eCC, it may not go across the interface into the EHR-s CAP does not mandate use of discrete data for clinical care - just requires the data elements be present Does this include the AOEs that are required for Pap smears? FHIR representation of the eCC’s being worked on specimen tracking is differnt in the EHR-s from the pathology result section - so need to watch for potential discrepancy between what the surgeon enters manually Has the eCC been evaluated for use of the LOINC LHC forms (survey panels)? Canada added the individual discrete readings back in 2006 example: 85905-8 They are also being represented in SCT models - working on solid tumors at Winter 2018 LOINC meeting this was a discussion item - agreement with CAP to have LOINCs created for the high volume, but then that contract was discontinued due to contractual / licensing restrictions 😞 - would be great if that could get resurrected, because MU requires LOINC
the new LOINC/SNOMED agreement will need to review the interlectual property agreements LOINC has (for use in the SNOMED CT LOINC extension) have speicmen in clincial lab and pathology lab would be good to harmonize data elements around clinical genomics data as well need everything in a single code system? support for more code systems will require updates to the underlying EHR-s and LIS codes - often data dictionary an ony be mapped to a single code system goal would be to encode the most granular clincial context for the data International EHR-s and LIS vendors will have to support multiple code systems based on legislation and jurisdictional regulations Epic Cerner MediTech CliniSys / Mimps
Is there a way we can help? Could make LOINC Committee aware of this topic |
Review LabMCoP confluence space | |
TRUU-Lab follow up | Dr. Sing will provide update on TRUU Lab for CLIAC April - update to this presentation from 2018 https://www.cdc.gov/cliac/docs/addenda/cliac0919/13_TRUU-LAB_Singh.pdf Also present to Clinical Lab Partners Forum SHIELD might put up a Test Naming topic call April 11 Some questions from SHIELD: - Riki to Follow up with Dr. Singh on getting this information out there
|
Reporting Biomarkers to Cancer registries | NOT DISCUSSED |
Specimen CMT - Progress | NOT DISCUSSED https://app.smartsheet.com/sheets/h6JWqw5v9pwvrqWMq9r4g85CXjv9M8VvVqvHRwc1?view=grid |
Specimen CMT - Hosting Options | NOT DISCUSSED email update from John: I talked to SNOMED International and I am going to be setting up a special area in the US Extension where I can do some test modeling and create new attribute relationships. Once I have that setup, I will try doing some test models off the existing content and see what I can come up with |
Specimen CMT - education | NOT DISCUSSED |
Specimen CMT - potential pilot sites | Goal is to have some implementers lined up by April - so who to reach out to? - Andrea will see, if she can use the Specimen CMT content in their cancer project and report back
- Raj to reach out to CAP to get contacts at vendors that we don’t have contact for - see here: Vendor Connections
|
Specimen CMT - tracking implementation impact Setting baseline Define metrics
| NOT DISCUSSED |
Specimen CMT - Compare to NHS Medical Terminology testing | NOT DISCUSSED |
Specimen CMT - review of terms with questions | NOT DISCUSSED |
Future projects for this call after CMT | NOT DISCUSSED |
From Chat:
Andrea Pitkus 12:13 PM
The CAP eCP allows for capture discretely and Raj is right it may or may not be stored, or transmitted discretely, much less encoded
...
Recording of the call: https://www.aphlweb.org/aphl_departments/Strategic_Initiatives_and_Research/IPMG/ConfigMgt/LabMCoP/Meeting Notes/2023-03-02_LabMCop Calls.zip
Action items
Quick decisions not requiring context or tracking
For quick, smaller decisions that do not require extra context or formal tracking, use the “Add a decision…” function here.
Decisions requiring context or tracking
For decisions that require more context (e.g., documentation of discussion, options considered) and/or tracking, use the decision template to capture more information.
| Create from Template |
|---|
| spaceKey | CLP |
|---|
| blueprintModuleCompleteKey | com.atlassian.confluence.plugins.confluence-business-blueprints:decisions-blueprint |
|---|
| contentBlueprintId | 7df0012f-f16f-4314-9440-69be210d9c3c |
|---|
| templateName | 7df0012f-f16f-4314-9440-69be210d9c3c |
|---|
| buttonLabel | Create decision from decision template |
|---|
|